Johnson & Johnson Revenue
Net Revenue of Johnson & Johnson 2001-2021
Amounts are in $millions.
| Year | Revenues ($millions) |
| 2021 | $93,775 |
| 2020 | $82,584 |
| 2019 | $82,059 |
| 2018 | $81,581 |
| 2017 | $76,450 |
| 2016 | $71,890 |
| 2015 | $70,074 |
| 2014 | $74,331 |
| 2013 | $71,312 |
| 2012 | $67,224 |
| 2011 | $5,030 |
| 2010 | $61,587 |
| 2009 | $61,897 |
| 2008 | $63,747 |
| 2007 | $61,095 |
| 2006 | $53,324 |
| 2005 | $50,514 |
| 2004 | $47,348 |
| 2003 | $41,862 |
| 2002 | $36,298 |
| 2001 | $32,317 |
2021: The net sales of Johnson and Johnson increased to $93,775 million in fiscal 2021 compared to $82,584 million in 2020. The company had $47,156 million worth net sales in the US and $46,619 million in the international markets in 2021.
Johnson & Johnson and its subsidiaries (the Company) have approximately 135,100 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the field of health care. Johnson & Johnson is a holding company, with more than 260 operating companies conducting business in nearly all countries of the world. The Company’s main focus are is human health and well-being. Johnson & Johnson was incorporated in the State of New Jersey in 1887.
The revenue of Johnson & Johnson rose to $81,581 million in 2018 from $76,450 million in 2017.